One patient with AML with a CBFB-MYH11 fusion could be assigned to risk-based therapy and the diagnosis of gamma-delta T-cell lymphoma [38, 39] was also corroborated by CNV with isochromosome 7q. Here, MYH11 is linked to acute myeloid leukemia.